Clinical Trials | February 13, 2024
Lord's Mark Industries files patent for bio-chemistry reagents; Targets revenue of Rs. 200 Cr
These re-agent and diagnostic test kits come with 99.7% accuracy
These re-agent and diagnostic test kits come with 99.7% accuracy
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The products will be manufactured at the company's facility in Bengaluru
The cognitively operated system is a mother patent invention, first launched in India
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Subscribe To Our Newsletter & Stay Updated
